Literature DB >> 24584117

MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Andreas Schober1, Maliheh Nazari-Jahantigh2, Yuanyuan Wei3, Kiril Bidzhekov4, Felix Gremse5, Jochen Grommes6, Remco T A Megens4, Kathrin Heyll3, Heidi Noels7, Michael Hristov4, Shusheng Wang8, Fabian Kiessling5, Eric N Olson9, Christian Weber10.   

Abstract

Atherosclerosis, a hyperlipidemia-induced chronic inflammatory process of the arterial wall, develops preferentially at sites where disturbed laminar flow compromises endothelial cell (EC) function. Here we show that endothelial miR-126-5p maintains a proliferative reserve in ECs through suppression of the Notch1 inhibitor delta-like 1 homolog (Dlk1) and thereby prevents atherosclerotic lesion formation. Endothelial recovery after denudation was impaired in Mir126(-/-) mice because lack of miR-126-5p, but not miR-126-3p, reduced EC proliferation by derepressing Dlk1. At nonpredilection sites, high miR-126-5p levels in endothelial cells confer a proliferative reserve that compensates for the antiproliferative effects of hyperlipidemia, such that atherosclerosis was exacerbated in Mir126(-/-) mice. In contrast, downregulation of miR-126-5p by disturbed flow abrogated EC proliferation at predilection sites in response to hyperlipidemic stress through upregulation of Dlk1 expression. Administration of miR-126-5p rescued EC proliferation at predilection sites and limited atherosclerosis, introducing a potential therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24584117      PMCID: PMC4398028          DOI: 10.1038/nm.3487

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  49 in total

1.  Notch controls retinal blood vessel maturation and quiescence.

Authors:  Manuel Ehling; Susanne Adams; Rui Benedito; Ralf H Adams
Journal:  Development       Date:  2013-06-19       Impact factor: 6.868

Review 2.  MicroRNAs in flow-dependent vascular remodelling.

Authors:  Peter Neth; Maliheh Nazari-Jahantigh; Andreas Schober; Christian Weber
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

3.  Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles.

Authors:  Felix Jansen; Xiaoyan Yang; Marion Hoelscher; Arianna Cattelan; Theresa Schmitz; Sebastian Proebsting; Daniela Wenzel; Sarah Vosen; Bernardo S Franklin; Bernd K Fleischmann; Georg Nickenig; Nikos Werner
Journal:  Circulation       Date:  2013-09-06       Impact factor: 29.690

4.  Conditional deletions refine the embryonic requirement for Dlk1.

Authors:  Oliver K Appelbe; Aleksey Yevtodiyenko; Hilmarie Muniz-Talavera; Jennifer V Schmidt
Journal:  Mech Dev       Date:  2012-10-08       Impact factor: 1.882

5.  AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.

Authors:  Pavani Mocharla; Sylvie Briand; Giovanna Giannotti; Carola Dörries; Philipp Jakob; Francesco Paneni; Thomas Lüscher; Ulf Landmesser
Journal:  Blood       Date:  2012-11-08       Impact factor: 22.113

Review 6.  MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?

Authors:  Yuanyuan Wei; Maliheh Nazari-Jahantigh; Peter Neth; Christian Weber; Andreas Schober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-16       Impact factor: 8.311

7.  Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress.

Authors:  Jing Zhou; Yi-Shuan Li; Phu Nguyen; Kuei-Chun Wang; Anna Weiss; Yi-Chun Kuo; Jeng-Jiann Chiu; John Y Shyy; Shu Chien
Journal:  Circ Res       Date:  2013-04-19       Impact factor: 17.367

8.  CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.

Authors:  Shamima Akhtar; Felix Gremse; Fabian Kiessling; Christian Weber; Andreas Schober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-07       Impact factor: 8.311

9.  Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis.

Authors:  Martin M N Schmitt; Remco T A Megens; Alma Zernecke; Kiril Bidzhekov; Nynke M van den Akker; Timo Rademakers; Marc A van Zandvoort; Tilman M Hackeng; Rory R Koenen; Christian Weber
Journal:  Circulation       Date:  2013-09-24       Impact factor: 29.690

10.  The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.

Authors:  Yuanyuan Wei; Maliheh Nazari-Jahantigh; Lily Chan; Mengyu Zhu; Kathrin Heyll; Judit Corbalán-Campos; Petra Hartmann; Anna Thiemann; Christian Weber; Andreas Schober
Journal:  Circulation       Date:  2013-03-19       Impact factor: 29.690

View more
  234 in total

Review 1.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 2.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

3.  Maternal and zygotic Zfp57 modulate NOTCH signaling in cardiac development.

Authors:  Yulia Shamis; Dana E Cullen; Lizhi Liu; Guan Yang; Sheau-Fang Ng; Lijuan Xiao; Fong T Bell; Chelsea Ray; Sachiko Takikawa; Ivan P Moskowitz; Chen-Leng Cai; Xiao Yang; Xiajun Li
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 4.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

5.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

Review 6.  Implications for MicroRNA involvement in the prognosis and treatment of atherosclerosis.

Authors:  Samira Tabaei; Seyyedeh Samaneh Tabaee
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 7.  Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology.

Authors:  Andrea Caporali; Magnus Bäck; Mat J Daemen; Imo E Hoefer; Elizabeth A Jones; Esther Lutgens; Christian M Matter; Marie-Luce Bochaton-Piallat; Arndt F Siekmann; Judith C Sluimer; Sabine Steffens; José Tuñón; Cecile Vindis; Jolanda J Wentzel; Seppo Ylä-Herttuala; Paul C Evans
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

8.  Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency.

Authors:  Christina V Theodoris; Molong Li; Mark P White; Lei Liu; Daniel He; Katherine S Pollard; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

Review 9.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 10.  The role of miRNAs in cardiovascular disease risk factors.

Authors:  Joy N Jones Buie; Andrew J Goodwin; James A Cook; Perry V Halushka; Hongkuan Fan
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.